Abstract
Nucleoside analogs (NAs) have been used extensively in both antitumor and antiviral therapies. Their general mechanism of action has been postulated to result from incorporation into DNA, leading to disruption of DNA synthesis and DNA polymerase inhibition. To further explore the antitumor mechanisms of NAs we have evaluated ganciclovir (GCV), an NA antiviral agent, in herpes simplex virus thymidine kinase (HSV-TK) gene-modified tumor cells. This system allows specific evaluation of the antitumor effects of NAs because the antitumor effect is directly related to the phosphorylation of the prodrug GCV by the HSV-TK enzyme in the gene-modified tumor cells. We demonstrated that GCV incorporates into DNA and inhibits DNA polymerase, as has been observed in HSV-infected cells and with other antitumor NAs in tumor cells. A novel observation is that GCV activates MAP kinase within 1 hour of GCV exposure. This activation directly correlates with cytotoxicity, because inhibition of the MAP kinase extracellular regulated kinase (Erk) by PD98059, reversed GCV-mediated cytotoxicity. This effect appears to be specific to the Erk pathway, because inhibition of the p38 kinase with SB203580 had no effect on cytotoxicity. Further, GCV does not ...Continue Reading
References
Jun 12, 1992·Science·K W CulverR M Blaese
Feb 1, 1985·Journal of Virology·D M CoenM J Retondo
Feb 1, 1987·Antimicrobial Agents and Chemotherapy·Y S Chun, N H Park
Jun 1, 1987·Antimicrobial Agents and Chemotherapy·M H St ClairP A Furman
Jan 27, 1986·Life Sciences·S AlbouzN Baumann
Jan 1, 1980·Advances in Enzyme Regulation·G B Elion
Feb 9, 1996·The Journal of Biological Chemistry·N L JohnsonG L Johnson
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·E GoillotI Sanchez
Feb 21, 1997·Biochemical Pharmacology·J W DarnowskiF A Goulette
Aug 14, 1999·Immunology·L ZhuC Anasetti
Sep 14, 1999·The American Journal of Physiology·E E Dupont-VersteegdenC A Peterson
Oct 3, 1999·Cancer Gene Therapy·K A WhartenbyP Calabresi
Aug 10, 2000·Cancer·M HejnaW Scheithauer
Mar 10, 2001·Nature·L Chang, M Karin
Mar 30, 2001·The Journal of Biological Chemistry·E CocolakisJ J Lebrun
Apr 21, 2001·Oncogene·S S BacusR Seger
May 30, 2001·Mutation Research·Z Herceg, Z Q Wang